Such studies could guide still -
experimental therapies such as transcranial magnetic stimulation, which aims to suppress or boost brain activity in targeted areas through electrical currents.
Not exact matches
Bellicum is among the flurry of biotechs investing heavily into cell
therapies such as
experimental chimeric antigen receptor T - cell (CAR - T) treatments for cancer (this is the next - gen treatment that involves reprogramming immune cells to become cancer killers and has shown promise in blood cancers, which Bellicum specializes in).
When the World Health Organization recently named blood transfusions from Ebola survivors as its priority
experimental therapy for the disease ravaging west Africa there was only one major problem: no data indicating that
such transfusions work.
This has led to the
experimental use of antigenspecific
therapies (using a substance to initiate an immune response) to prevent, stabilize, or reverse immunerelated diseases,
such as allergies and multiple sclerosis.
Experimental approaches
such as gene
therapy are also being investigated, but Dr. Rudnicki's research suggests that these approaches will have to be modified so that they target muscle stem cells as well as muscle fibres.
That would be a huge boon for
therapy by allowing doctors to combine visual imaging,
such as MRI scans, of tumors with knowledge of their genetic make - up, says
experimental oncologist Janusz Rak of McGill University Health Centre in Montreal, Canada.
Clinical research activities are focused on the implementation of
experimental protocols based on gene or cell
therapy for the treatment of genetic blood disorders
such as ADA - SCID, Wiskott - Aldrich Syndrome, Metachromatic Leukodystrophy, Beta - thalassemia, Chronic granulomatous disease, Mucopolysaccharidosis Type I (Hurler).
Lymphoma is
such a common malignancy in humans that there are always new drugs, new protocols and
experimental therapy that your regular veterinarian may not be familiar with.